Your session is about to expire
← Back to Search
Montelukast for Alzheimer's Disease (BUENA Trial)
BUENA Trial Summary
This trial is testing a new way to take montelukast, a drug commonly used to treat allergies, to see if it is safe and effective in treating Alzheimer's disease.
BUENA Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBUENA Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BUENA Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't had cancer in the last 5 years, except for certain types that were fully treated.My recent brain scan suggests I may have Alzheimer's Disease.I do not have unstable heart or blood vessel conditions.I don't use strong painkillers more than three times a week and follow specific medication guidelines.I do not have any uncontrolled psychiatric disorders or severe illnesses.My heart tests, physical exam, and lab tests show no significant issues.My medications for other conditions have been the same for at least 2 weeks.My condition is mild to moderate Alzheimer's Disease.I have been taking donepezil, rivastigmine, or galantamine daily for at least 3 months.I have taken memantine in the last 2 months.
- Group 1: Group A
- Group 2: Group B
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How is Montelukast buccal film typically employed?
"Montelukast buccal film is not only effective in treating exercise-induced bronchospasm, but also in managing other conditions like perennial allergic rhinitis (par), seasonal allergic rhinitis, and asthma."
Are people currently being recruited for this experiment?
"The listings on clinicaltrials.gov show that this experiment is ongoing and looking for more test subjects. The trial was originally posted on 11/26/2018, with the latest update being from 11/15/2022. So far, 14 hospitals have enrolled 70 patients combined."
Are there a considerable amount of hospitals running this trial in state?
"Currently, this trial is open to patients located at Recherche Neuro-Hippocampe in Gatineau, Quebec; Diex Recherche Sherbrooke Inc. in Sherbrooke, Nova Scotia; and Centre hospitalier universitaire de Québec -Université Laval in Québec City, British Columbia along with 14 other sites."
Can you tell me if there is a precedent for using Montelukast in this way?
"The first study for the efficacy of montelukast buccal film was completed in 2013. As of now, there have been a total 188 studies with 22 still ongoing. A majority of these trials are situated in Gatineau, Quebec."
Does the Montelukast buccal film have FDA approval?
"While there is some evidence to support the safety of Montelukast, as this drug is still in Phase 2 of clinical trials, there is currently no data supporting its efficacy."
Are there any limitations on the amount of people who can be in this experiment?
"The clinical trial is currently looking for patients between 14 sites, as indicated by the information on clinicaltrials.gov. The study was originally posted on 11/26/2018 and was most recently updated on 11/15/2022. They are looking for a total of 70 patients."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger